L'Oreal Buys Stake in Swiss Skincare Company Galderma
Provided by
Dow Jones
By Mauro Orru
L'Oreal agreed to acquire a minority stake in Swiss skincare company Galderma, banking on its dermatology portfolio.
The French cosmetics giant said it was acquiring a 10% stake in Galderma from EQT-led Sunshine SwissCo, Abu Dhabi Investment Authority and Auba Investment Pte. L'Oreal didn't disclose the value of the stake, but said it would fund the deal through cash and credit lines.
A 10% stake in Galderma is valued at roughly 1.59 billion Swiss francs ($1.85 billion) based on the stock's Friday closing price of CHF66.96.
Write to Mauro Orru at mauro.orru@wsj.com
(END) Dow Jones Newswires
August 05, 2024 01:46 ET (05:46 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks
United States